Muir-Torre syndrome is a predictor of gastric cancer (clinical observation)
https://doi.org/10.37493/2307-910X.2023.4.36
Abstract
Muir-Torre syndrome is a hereditary autosomal dominant syndrome that belongs to HNPCC (Lynch syndrome), being its subspecies. The disease is associated with a high risk of developing colorectal cancer, as well as other cancers of the gastrointestinal tract, genitourinary tract and skin lesions in the form of tumors of the sebaceous glands and keratoacanthus. Visceral cancer in the syndrome is characterized by multiple localization and a low degree of malignancy. Mutations in the genes MSH2 and MLH1 - loci 2p22–p21 and 3p21.3 in the DNA repair system were detected in patients with Muir-Torre syndrome, which leads to its microsatellite instability. Skin tumors may precede visceral cancer, may develop in parallel with the malignant process of internal organs. The importance of timely diagnosis of skin neoplasms (sebaceous gland adenomas and keratoacanthus) as a marker of Muir-Torre syndrome is emphasized. The article presents a clinical case of Muir-Torre syndrome in a 50-year-old patient, which was manifested by a combination of gastric cancer, multiple adenomas of the sebaceous glands and solitary keratoacanthoma. The first manifestations of the syndrome were adenomas of the sebaceous glands of the facial skin, mistakenly regarded by dermatologists as a papular form of rosacea. After 4 years, the patient underwent surgery for a keratoacanthoma of the shin, a couple of months later, the patient was diagnosed with stage IIA gastric cancer (T3N0M0), a ring-cell variant. Skin rashes were regarded as hereditary paraneoplastic Muir–Torre syndrome. In order to detect oncological diseases early, it is necessary to improve the qualifications of doctors in the clinic and diagnosis of hereditary paraneoplastic dermatoses.
About the Authors
Yu. A. DykhnoRussian Federation
Yuri A. Dykhno – Distinguished Doctor of the Russian Federation, Dr. Sci. (Medicine), Professor, Professor of the Department of Oncology and Radiation Therapy with a course in
1, Partizan Zheleznyak St., Krasnoyarsk, 660022, SPIN code: 2505-2322, AuthorID: 108203
Yu. V. Karacheva
Russian Federation
Yulia V. Karacheva – Dr. Sci. (Medicine), Professor, Head of the Department of Dermatovenerology named after prof. V.I. Prokhorenkov with a course in Cosmetology and Software
1, Partizan Zheleznyak St., Krasnoyarsk, 660022, +79233531015, SPIN: 4789-9178, AuthorID: 338079
Yu. Yu. Vinnik
Russian Federation
Yuri Yu. Vinnik – Dr. Sci. (Medicine), Professor, Chief Physician;
Professor of the Department of Dermatovenerology named after prof. V.I. Prokhorenkov with a course in Cosmetology and Software
79, Bryanskaya St., Krasnoyarsk, 660099;
1, Partizana Zheleznyaka St., Krasnoyarsk, 660022, +79135345145, AuthorID: 288354
V. S. Tsikh
Russian Federation
Victoria S. Tsikh – Dermatovenerologist, Postgraduate Student of the Department of Dermatovenerology named after prof. V.I. Prokhorenkov with a course in Cosmetology and Software
1, Partizan Zheleznyak St., Krasnoyarsk, 660022, +79131775108
References
1. Kaminsky AV, Plaksa IL. The case of Muir-Torre syndrome associated with a hereditary mutation in the MSH2 gene. Clinical and experimental morphology. 2021;10(1):66-70. (In Russian).
2. Molochkov VA, Kuntsevich ZhS, Dibirova SD, Molochkova YuV, Kazantseva KV. Clinical observation of Muir-Torre syndrome. Russian Journal of Skin and Venereal Diseases. 2014;3:9-11. (In Russian).
3. Molochkov VA, Kuntsevich ZhS, Khlebnikova AN, Vlasova MA, Bochkareva EV, Lavrov DB. The case of Muir-Torre syndrome. Russian Journal of Skin and Venereal Diseases. 2011;14(5):31-33. (In Russian).
4. Tsukanov AS, Shelygin YuA, Semenov DA, Pikunov DYu, Polyakov AV. LynchSyndrome. The current state of the problem. Medicalgenetics. 2017;16(2):11-18. (In Russian).
5. Shnaider NA, Dykhno YuA, Ezhikova VV. Paraneoplasticheskii nevrologicheskii sindrom. Novosibirsk; 2015. 218 p. (In Russian).
6. Abbas O, Mahalingam M. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. Journal of Cutaneous Pathology. 2009;36(6):613-9. https://doi.org/10.1111/j.1600-0560.2009.01248.x. PMID: 19515040.
7. John AM, Schwartz RA. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management. Journal of the American Academy of Dermatology. 2016;74(3):558-566. https://doi.org/10.1016/j.jaad.2015.09.074
8. Bhaiji F, Brown AS. Muir-Torre syndrome. Archives Pathology & Laboratory Medicine. 2014;138(12):1685-9. https://doi.org/10.5858/arpa.2013-0301-RS. PMID: 25427047.
9. Cheah KY, Dsusa L, Taggart MW, Schlete EJ, Turturro F. Diffuse large B-cell lymphoma with microsatellite instability developing in the setting of Muir-Torre variant hereditary non-polyposis colon cancer. Journal Clinical Pathology. 2015;68:755-757.
10. Kacerovská D, Kazakov DV, Cerná K, Hadravský L, Michal M Jr, Dostál J, Skálová A Jr, Michal M. Muir-Torre syndrome--a phenotypic variant of Lynch syndrome. CeskPatol. 2010;46(4):86-94. PMID: 21313735 Review. Czech.
11. Schwartz RA, Torre DPJ. The Muir-Torre syndrome: a 25-year retrospect. Journal of the American Academy of Dermatology. 1995;33(1):90-104. https://doi.org/10.1016/0190-9622 (95)90017-9. PMID: 7601953.
Review
For citations:
Dykhno Yu.A., Karacheva Yu.V., Vinnik Yu.Yu., Tsikh V.S. Muir-Torre syndrome is a predictor of gastric cancer (clinical observation). Modern Science and Innovations. 2023;(4):298-305. (In Russ.) https://doi.org/10.37493/2307-910X.2023.4.36